-
Symbol
-
CPRX on Nasdaq
-
Investment type
-
Equity / COMMON STOCK
-
Latest Disclosed Shares Owned
-
3,133,011 shares
-
Security Ownership %
-
2.6%
Deerfield Mgmt, L.P. ownership in CATALYST PHARMACEUTICALS, INC. COMMON STOCK (CPRX)
13 Feb 2025 - Deerfield Mgmt, L.P. has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 3,133,011 shares of CATALYST PHARMACEUTICALS, INC. COMMON STOCK (CPRX).
This represents 2.6% ownership of the company.
This is the first filing by James E. Flynn disclosing ownership of CATALYST PHARMACEUTICALS, INC. COMMON STOCK (CPRX).